SFJ Pharmaceuticals
is a Private company. SFJ Pharmaceuticals generates $367.2K in revenue per employee SFJ Pharmaceuticals's top competitor is Mapp Biopharmaceutical, led by Kevin Whaley, who is their CEO. SFJ Pharmaceuticals has 15 followers on Owler.SFJ Pharmaceuticals
is a Private company. SFJ Pharmaceuticals generates $367.2K in revenue per employee SFJ Pharmaceuticals's top competitor is Mapp Biopharmaceutical, led by Kevin Whaley, who is their CEO. SFJ Pharmaceuticals has 15 followers on Owler.
CEO
Add
News
Mar 30, 2025
GlobalNewswire
Press Release: SFJ Pharmaceuticals : SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Surgery or Experiencing Major Bleeding
Jun 02, 2023
Global Legal Chronicle
SFJ Pharmaceuticals: SERB Pharmaceuticals' Partnership with SFJ Pharmaceuticals
May 12, 2023
Pharamceutical Technology
SFJ Pharmaceuticals: SERB Pharmaceuticals buys US rights for bentracimab from SFJ
May 11, 2023
BioSpace
SFJ Pharmaceuticals: SERB Pharmaceuticals and SFJ Pharmaceuticals announce a U.S. partnership for bentracimab, a ticagrelor reversal agent
May 11, 2023
Benzinga
SFJ Pharmaceuticals: SERB Pharmaceuticals and SFJ Pharmaceuticals announce a U.S. partnership for bentracimab, a ticagrelor reversal agent
Feb 01, 2023
Global Legal Chronicle
SFJ Pharmaceuticals: SFJ Pharmaceuticals' Acquisition of Bentracimab Assets
Jan 17, 2023
Acrofan
SFJ Pharmaceuticals: SFJ Pharmaceuticals Announces Closing of Transfer of Bentracimab Assets from PhaseBio Pharmaceuticals
Sep 28, 2022
Benzinga
SFJ Pharmaceuticals: PhaseBio Might Have To Return Global Rights To Its Lead Program
Aug 10, 2021
MarketScreener
SFJ Pharmaceuticals: PhaseBio Pharmaceuticals : and SFJ Pharmaceuticals Announce Approval of IND Application in China for Bentracimab
Feb 18, 2021
The Pharma Letter
SFJ Pharmaceuticals: Nektar collaborates with SFJ Pharma and Merck on bempegaldesleukin
SFJ Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10